Skip to main content

Fore Capital, LLC

Position in DFTX — Definium Therapeutics, Inc.

CIK 1714672 New York, NY

Position in DFTX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$940,800
New position
Shares Held
20,000
first reported quarter
Ownership
0.015%
of shares outstanding
% of Portfolio
6.19%
of 13F equity value
Holder Rank
#176
of 358 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Derivatives in DFTX

reported options exposure · as of Jun 30, 2026
CallValue
$705,600
CallShares
15,000
PutValue
$3,763,200
PutShares
80,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Fore Capital, LLC holds $1,497,742 across 3 Biotechnology names. DFTX ranks #1 (62.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DFTX
Definium Therapeutics, Inc.
This page
20,000 $940,800

All Filings in DFTX

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $705,600 15,000
2026-06-30 $940,800 20,000
2026-06-30 $3,763,200 80,000